Natural History of Hypertrophic Cardiomyopathy: A Population-Based Study, 1976 Through 1990
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background Hypertrophic cardiomyopathy is a disease entity characterized by marked heterogeneity in morphology and natural history. Most of our knowledge of the natural history of this disorder derives from the study of hospital-based populations and is influenced by referral bias. Therefore, this population-based study was undertaken to examine the natural history of hypertrophic cardiomyopathy among unselected residents of Olmsted County, Minnesota. Methods and Results Patients with hypertrophic cardiomyopathy, confirmed by echocardiography, were identified by use of the resources of the Rochester Epidemiology Project. Patients with the echocardiographic features of hypertrophic cardiomyopathy but with long-standing hypertension requiring drug therapy were categorized as having hypertensive hypertrophic cardiomyopathy. Baseline clinical details and follow-up events were obtained by retrospective chart review. Thirty-seven patients were diagnosed with hypertrophic cardiomyopathy and 24 with hypertensive hypertrophic cardiomyopathy. Eight additional patients were first diagnosed at autopsy. The mean age of the 37 patients with hypertrophic cardiomyopathy was 59±20 years (range, 1 week to 92 years); the mean ventricular septal thickness was 17.5±3 mm. Follow-up was obtained for a median of 7.7 years (range, 45 days to 17.2 years). The 1- and 5-year survival rates were 95% and 92%, respectively; these rates did not differ from those of an age- and sex-matched population ( P =NS). The annual risk of cardiac death was 0.7%. The mean age of patients with hypertensive hypertrophic cardiomyopathy was 79±8 years (range, 62 to 91 years), and the mean ventricular septal thickness was 19±2.5 mm. Follow-up was obtained for a median of 2.8 years (range, 4 days to 16.7 years). The 1- and 5-year survival rates were 75% and 43%, respectively, which differed sharply from the expected rates of 94% and 70% ( P =.0028). The annual risk of cardiac death was 5%. Atrial fibrillation and evidence for myocardial infarction on ECG, use of digoxin and diuretics, and a high New York Heart Association functional class at presentation were all associated with decreased survival by multivariate analysis for both groups combined. A history of myocardial infarction, atrial fibrillation, and mitral annular calcification at presentation were associated with cardiac death. Conclusions Hypertrophic cardiomyopathy is a more benign disease than previously reported from tertiary referral centers. Patients assessed as having hypertensive hypertrophic cardiomyopathy represent a subset at higher risk for cardiac and noncardiac death, with an overall decreased survival rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 777
FRANK, S., & BRAUNWALD, E. (1968) · Circulation · doi:10.1161/01.cir.37.5.759 · Cited by 660
Hypertensive Hypertrophic Cardiomyopathy of the Elderly
Topol, E. J., Traill, T. A., & Fortuin, N. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501313120504 · Cited by 646
Codd, M. B., Sugrue, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 640
Self-citationMcKenna, W., Deanfield, J., Faruqui, A., England, D., Oakley, C., & Goodwin, J. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90535-x · Cited by 630
Maron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 495
Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population
Spirito, P., Chiarella, F., Carratino, L., Berisso, M. Z., Bellotti, P., & Vecchio, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201201 · Cited by 326
Cited by
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Hypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
Lipshultz, S. E., Sleeper, L. A., Towbin, J. A., Lowe, A. M., Orav, E. J., Cox, G. F., Lurie, P. R., McCoy, K. L., McDonald, M. A., Messere, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021715 · Cited by 890
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 818
Self-citationMoon, J. C. C., McKenna, W. J., McCrohon, J. A., Elliott, P. M., Smith, G. C., & Pennell, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00189-x · Cited by 766
Writing Committee Members, Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., et al. (2006) · Europace · doi:10.1093/europace/eul108 · Cited by 738
Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., & Steinberger, J. (2006) · Circulation · doi:10.1161/circulationaha.106.179568 · Cited by 707
Maron, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00479-2 · Cited by 698
Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 677
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
Choudhury, L., Mahrholdt, H., Wagner, A., Choi, K. M., Elliott, M. D., Klocke, F. J., Bonow, R. O., Judd, R. M., & Kim, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02602-5 · Cited by 627
Bruder, O., Wagner, A., Jensen, C. J., Schneider, S., Ong, P., Kispert, E.-M., Nassenstein, K., Schlosser, T., Sabin, G. V., Sechtem, U., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.007 · Cited by 590
Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort
Maron, B. J. (1999) · JAMA · doi:10.1001/jama.281.7.650 · Cited by 554
Long-term outcome in patients with apical hypertrophic cardiomyopathy
Eriksson, M. J., Sonnenberg, B., Woo, A., Rakowski, P., Parker, T. G., Wigle, E. D., & Rakowski, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01778-8 · Cited by 476
Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J., Cox, G. F., Lurie, P. R., Orav, E. J., & Towbin, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.621185 · Cited by 474
The Molecular Genetic Basis for Hypertrophic Cardiomyopathy
Marian, A. J., & Roberts, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1340 · Cited by 438
Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy
Olivotto, I., Maron, M. S., Adabag, A. S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.043 · Cited by 432
Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418
Self-citationGenetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
ALCALAI, R., SEIDMAN, J. G., & SEIDMAN, C. E. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00965.x · Cited by 387
Daubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C. W., & Weintraub, R. G. (2006) · Circulation · doi:10.1161/circulationaha.106.635128 · Cited by 382
Rich, M. W. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02968.x · Cited by 379
Maron, B. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01282-8 · Cited by 370
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 322
Self-citationHistorical trends in reported survival rates in patients with hypertrophic cardiomyopathy
Elliott, P. M., Gimeno, J. R., Thaman, R., Shah, J., Ward, D., Dickie, S., Tome Esteban, M. T., & McKenna, W. J. (2006) · Heart · doi:10.1136/hrt.2005.068577 · Cited by 295
Cardim, N., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 284
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Self-citationSiontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276
Self-citationThe pathology of hypertrophic cardiomyopathy
Hughes, S. E. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01835.x · Cited by 264
Elliott, P. M., Sharma, S., Varnava, A., Poloniecki, J., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257
Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 255
Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M. (2010) · EP Europace · doi:10.1093/europace/eup431 · Cited by 176
Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., van den Berg, M. P., Volders, P. G. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr092 · Cited by 83
Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy
Finocchiaro, G., Pinamonti, B., Merlo, M., Brun, F., Barbati, G., & Sinagra, G. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328356a231 · Cited by 12
Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy
Heitner, S. B., & Fischer, K. L. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.004 · Cited by 3
Metadata
- Authors
- Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J.
- Venue
- Circulation
- Published
- 1995-11
- Volume
- 92
- Issue
- 9
- Pages
- 2488-2495
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2030627386
- Cited by
- 264
- References
- 30
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.